- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 04.04. | Cadence Minerals - Amapá optimisation adds value | 172 | This year will be important for Cadence Minerals' major asset, the Amapá iron ore project in Brazil. Cadence recently announced the results of an optimisation study that points to the potential to increase... ► Artikel lesen | ||
| 04.04. | Altron - Rising star | 210 | Altron is a South African-based provider of platforms and IT services, helping businesses transform and operate their IT. As part of the plan to refocus on strategic growth opportunities and to improve... ► Artikel lesen | ||
| 04.04. | SIGA Technologies - Positive signals abound | 218 | SIGA Technologies announced a strategic step in fortifying its distribution partner, Meridian, allowing greater control over planning and executing its international development efforts, a key growth... ► Artikel lesen | ||
| 03.04. | Sareum Holdings - A decisive period ahead for SDC-1801 | 102 | Sareum Holdings' H124 results highlighted the company's swift progress for lead asset SDC-1801, since gaining regulatory approval in Australia to start human studies in mid-CY23. SDC-1801, a TYK2/JAK1... ► Artikel lesen | ||
| 03.04. | The Metals Company - Growing up | 249 | The Metals Company (TMC) is approaching a critical phase in its development. As key milestones are achieved, so the project will be de-risked and the valuation expand. Of particular note are the anticipated... ► Artikel lesen | ||
| 03.04. | Immix Biopharma - Reaffirmed long-term focus on outpatient CAR-T | 218 | Immix Biopharma is continuing its strategic pivot towards exploring non-traditional indications for its CAR-T asset, NXC-201, leading with relapsed/refractory (r/r) amyloid light chain amyloidosis (ALA).... ► Artikel lesen | ||
| 03.04. | Cordel Group - Positive steps towards ambitious FY24 goals | 145 | Cordel's Q324 update shows progress towards the group's FY24 revenue expectation and other objectives, supporting our forecasts. Doubling the customer base by year-end is a key milestone, which encouragingly... ► Artikel lesen | ||
| 03.04. | Topps Tiles - Market tough through H124 | 138 | Topps Tiles' (TPT's) H124 update shows that trading deteriorated further in Q224, following the weakness that began in Q124. Management attributes the decline to the soft external environment as noted... ► Artikel lesen | ||
| 02.04. | Solid State - Anticipating record adjusted PBT in FY24 | 158 | Solid State's trading update affirms the sustained strength in demand throughout H224, resulting in record FY24 revenue and adjusted PBT ahead of prior consensus of £155m and £12.5m, respectively. This... ► Artikel lesen | ||
| 02.04. | Greggs - Showing us how it's done | 226 | The second full year of Greggs' five-year growth plan to double revenue by FY26 should be marked down as very successful, especially so given the challenging external environment. Unlike many consumer-facing... ► Artikel lesen | ||
| 02.04. | Information Services Corporation - A busy end to a record FY23 | 148 | In FY23, Information Services Corporation (ISC) enjoyed year-on-year top-line and adjusted operating profit growth, augmented by consistent organic expansion of its Services division and incremental... ► Artikel lesen | ||
| 02.04. | OSE Immunotherapeutics - Pipeline momentum builds into FY24 | 229 | OSE Immunotherapeutics' (OSE's) FY23 update summarised an active period for its clinical pipeline that was capped by the post-period $713m deal with AbbVie for preclinical asset OSE-230. The company... ► Artikel lesen | ||
| 28.03. | ABC arbitrage - FY23 results in line with market conditions | 264 | ABC arbitrage group (ABCA) reported net income of €16.5m in FY23, 43% lower than FY22, but in line with market conditions. Financial markets in 2023 were characterised by lower volatility than in the... ► Artikel lesen | ||
| 28.03. | Gym Group - The power of marginal gains | 213 | Gym Group has accompanied confirmation of FY23 profit resilience and continued buoyancy (like-for-like revenue up 12% in the first two months of 2024) with a clear commitment 'to accelerate, not reinvent... ► Artikel lesen | ||
| 28.03. | Mendus - Regulatory green light for CADENCE trial | 135 | The Human Research Ethics Committee (HREC) has provided the green light to commence enrolment for Mendus's AMLM22-CADENCE trial from April 2024. This Phase II trial in collaboration with the Australasian... ► Artikel lesen | ||
| 28.03. | Alpha Bank - Full steam ahead | 323 | Alpha Bank (Alpha) reported €611m in net profit, a 66% jump from FY22, as the bank benefited from an elevated interest rate environment with little impact from deposit migration and strong cost control.... ► Artikel lesen | ||
| 28.03. | Dalata Hotel - A strong hand | 191 | Dalata's FY23 deployment of €156m in high-profile hotel opportunities in London, Amsterdam and Edinburgh as well as the newly announced proposed redevelopment at Manchester Airport show the scale and... ► Artikel lesen | ||
| 28.03. | S4 Capital - Extension of recovery horizon | 251 | S4 Capital had a difficult FY23, as flagged, with reduced client confidence and spend, particularly from those clients in the tech sector, and on larger transformation projects. Management is cautious... ► Artikel lesen | ||
| 27.03. | Datatec - FY24 revenue growth of 5.8% | 203 | Datatec expects to report revenue of $5.44bn for FY24, up 5.8% y-o-y, and noted that the quality of earnings improved in the year. During H224, Westcon International continued to deliver a strong financial... ► Artikel lesen | ||
| 27.03. | AG Barr - Fizzing away | 185 | AG Barr's (BAG's) FY23 results highlighted the strength of the brand portfolio as group volumes (+2.4%) outperformed the UK soft drinks category decline of 2.9%. Key brands IRN-BRU (33% of FY24 revenue)... ► Artikel lesen | ||
| 27.03. | Kolibri Global Energy - FY23 reserves show solid replacement rates | 190 | Kolibri (KEI) released its annual reserves statement, which showed good replacement rates despite a visible increase in average production in FY23. At end-2023, the company's total gross proved reserves... ► Artikel lesen | ||
| 26.03. | Recce Pharmaceuticals - R&D advance (A$11.18m) extends runway | 121 | Recce Pharmaceuticals recently received A$11.18m as an R&D advance credit through an arrangement with Endpoints Capital for the R&D tax credit rebates that Recce expects to receive for FY23/FY24 and... ► Artikel lesen | ||
| 26.03. | Immix Biopharma - Marching towards US clinical trials for NXC-201 | 233 | Immix Biopharma is closer to dosing its first US patient for lead CAR-T asset NXC-201, with the appointment of the Memorial Sloan Kettering Cancer Center as the main clinical site for the company's... ► Artikel lesen | ||
| 25.03. | Ocean Wilsons Holdings - Strong FY23 results with strategic review in FY24 | 160 | Ocean Wilsons Holdings' (OCN's) FY23 results highlight a robust performance from the Brazilian subsidiary Wilson Sons, as well as growth from the investment portfolio. Our forecasts are under review... ► Artikel lesen | ||
| 25.03. | Kinepolis - On the move | 174 | Kinepolis is 'ready to tango', according to management, after impressive FY23 results defied last year's Hollywood strikes (H2 adjusted EBITDA up 26% despite 2% fewer visitors in Q4). Its confidence... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
